The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Https://www.virtualinvestorconferences.com/welcome
https://onlinexperiences.com/scripts/Server.nxp
Had to sign up to listen.
Nothing new, but I think it was a presentation in/for the USA.
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
OTC Markets
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading over 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market and Pink® Open Market.
Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN and OTC Link NQB are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
https://www.londonstockexchange.com/stock/EDEN/eden-research-plc/company-page
Price at mom 4.40-4.70p
market cap £24.27mio
Fair play to Eden .They make the most mundane statement sound full of excitement. Today is no exception
The CEO is going to a conference dragging himself from the hive of sales activity back at HQ !
This sounds impressive
"Recent regulatory approvals have converted to 55% rise in product sales in FY 2022.
The reality that's less than £600k and less than 15 % above 2019 " So SFA progress
He can certainly addrees an audience on how to extract £10ms from investors over many years without the salesi nventory to match thexpectaions
Https://www.aafarmer.co.uk/agronomy/maize-seed-treatment-reprieve-confirmed.html
News which extends the life of existing chemical seed treatment ls ansld seems to scotch any short term hopes for the Ecovelex product.
Anyone shed any light about the holdings in company back in october, notification of large holdings.
"Have you ever wondered what the word Corteva means? It’s a combination of two words: Corteva= heart + nature "
https://twitter.com/i/status/1724356310911607069
Market Musings by StockBox
"Revolutionizing Crop Protection & Sustainability w/ Sean Smith CEO of Eden Research2
3 Nov 2023
00:00 - Introduction (Who are Eden Research)
04:58 - What Are Sustainable Pesticides?
10:00 - The Market for Crop Protection
14:00 - Suite of Products & Ecovelex
31:41 - Mevalone
39:54 - Funded with £9M & Plans
48:00 Cedrox
51:27 - Newsflow and Summary
https://stockboxmedia.com/interviews/revolutionizing-crop-protection-sustainability-w-sean-smith-ceo-of-eden-research/
Https://www.voxmarkets.co.uk/articles/sean-smith-of-eden-research-funds-raised-will-accelerate-our-commercial-growth-215eee4/
"Recently Eden announced a fundraising totalling £9.9 million before expenses. Sean commented that the fundraise not only provides them with additional capital to commercialise further existing products and fund new areas of the business, but it also serves to strengthen their balance sheet and provide greater flexibility during this high-growth period.
Eden is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides."
Great additions to the share register especially Octopus although good to see Unicorn and Amati support.
Https://european-seed.com/docs/books/volume-10/issue-3/?page=28
Leonardo Costa, Corteva’s new EMEA Seed Applied Technologies Leader
Priceless
"Eden is expected to have a year-end cash balance of £7.8 million "
Leftover from a £10m capital raise. Although fair play to Farrington he can pick them. Tipped Nvidia ar Xmas for 2023 @ $153.4 . Current $438.38
I agree that it is a long term investment and high risk.
As such you invest money you can afford to write off.
The only predictable thing is the constant griping from @visoin 😀
The reality
The half year report in 2018 5 years ago H1 announced product sales of £0.68m
"I am sure that the remainder of 2018 will be another significant step-forward towards long-term success for Eden and I would like to thank you for your continued support." so he spouted at the time
Since then they have rolled on out across the globe
Went cap in hand to investor to raise
£10,4mn gross in 2020 whuch they have burned through
The increase in product sales for H1 is just £500k ahead of 2018
There is limited demad for their products !
Seen it before many time with small Pharma/Agric.
Yes it’s a slow burner but a winner
Lease Liabilities
There is a 6 figure sum for this .
Surely these aren't legacy issues relating to their old premises before moving into Milton Park .Delusions of grandeur
The Patience of Job.
Despite the blizzard of exciting news about roilouts the total amount of product sales for H1 increased by just £8k and revenue by just £10k !
It must be too wet, cold dry hot
They even managed to have manufacturing problems too.
Managed to ge the date wrong in the RNS referring to H1 2021 not H1 2022 in sales !
How long til another capital raising exercise when they chew through the latest ?
Well done Tonypeters! Great post/video! 2024 will be an interesting and exciting year for Eden.
"The stock market is a device for transferring money from the impatient to the patient". ( Warren Buffet)
Https://www.fhalmeria.com/noticia-33913-28/sipcam-utiliza-los-cinco-sentidos-para-presentar-el-fungicida-araw
"Araw is an innovative solution that combats multiple diseases and is also registered in organic farming,” concludes Mulas. A product that, as its slogan says, guarantees “protection until the end and quality from the beginning.”
Https://worldseed.org/event/euroseeds-congress-2023/
Platinum Partner: Corteva
https://euroseedscongress.com/participants-list/
Programme for 15th to 18th October 2023:
https://euroseedscongress.com/on-siteprogramme/
(2 hours Section on Maize and Sorghum could be interesting plus the fact that Corteva exhibiting) as:
https://european-seed.com/2023/09/whac-a-mole-in-malta/
https://euroseeds.eu/
https://euroseeds.eu/resources/
Https://www.miltonpark.co.uk/news/company-spotlight-eden-research/
Sounding pretty desperate that now relying on the odd hurricane for a minor sales boost
Meanwhile back in France
National production from France’s wine harvest in 2023 has been estimated between 44 million and 47 million hectolitres this year, up from 45.4 million hectolitres in 2022. That would be in line with, or exceed, the five-year average.
Https://www.thedrinksbusiness.com/2023/08/hurricane-hilary-strikes-southern-california/